

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 7.45456991 |
| 2 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 6.25186276 |
| 3 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 5.76249124 |
| 4 | axon extension involved in axon guidance (GO:0048846) | 5.76249124 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.69185130 |
| 6 | presynaptic membrane assembly (GO:0097105) | 5.46937691 |
| 7 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 5.19439419 |
| 8 | auditory behavior (GO:0031223) | 4.95513812 |
| 9 | dopaminergic neuron differentiation (GO:0071542) | 4.94785847 |
| 10 | regulation of respiratory system process (GO:0044065) | 4.92948136 |
| 11 | vocalization behavior (GO:0071625) | 4.78582785 |
| 12 | negative regulation of axon guidance (GO:1902668) | 4.78358286 |
| 13 | response to pheromone (GO:0019236) | 4.72581941 |
| 14 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.62871544 |
| 15 | dopamine transport (GO:0015872) | 4.56673212 |
| 16 | cochlea development (GO:0090102) | 4.47201662 |
| 17 | urinary tract smooth muscle contraction (GO:0014848) | 4.45131428 |
| 18 | postsynaptic membrane organization (GO:0001941) | 4.39397679 |
| 19 | presynaptic membrane organization (GO:0097090) | 4.37199422 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.36023323 |
| 21 | retinal cone cell development (GO:0046549) | 4.34184507 |
| 22 | regulation of respiratory gaseous exchange (GO:0043576) | 4.33165358 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.31627446 |
| 24 | serotonin metabolic process (GO:0042428) | 4.27329984 |
| 25 | positive regulation of gastrulation (GO:2000543) | 4.27038067 |
| 26 | daunorubicin metabolic process (GO:0044597) | 4.25269838 |
| 27 | polyketide metabolic process (GO:0030638) | 4.25269838 |
| 28 | doxorubicin metabolic process (GO:0044598) | 4.25269838 |
| 29 | regulation of DNA methylation (GO:0044030) | 4.23243775 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.16036883 |
| 31 | regulation of axon guidance (GO:1902667) | 4.13818862 |
| 32 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 4.13059567 |
| 33 | axonal fasciculation (GO:0007413) | 4.13008434 |
| 34 | regulation of female gonad development (GO:2000194) | 4.11987306 |
| 35 | catecholamine transport (GO:0051937) | 4.09486781 |
| 36 | retinal ganglion cell axon guidance (GO:0031290) | 4.05539479 |
| 37 | glutamate secretion (GO:0014047) | 4.03147440 |
| 38 | dendrite morphogenesis (GO:0048813) | 4.01467619 |
| 39 | regulation of feeding behavior (GO:0060259) | 3.98943306 |
| 40 | dendrite development (GO:0016358) | 3.95026018 |
| 41 | regulation of meiosis I (GO:0060631) | 3.94767749 |
| 42 | dermatan sulfate biosynthetic process (GO:0030208) | 3.94202870 |
| 43 | exploration behavior (GO:0035640) | 3.94168430 |
| 44 | mechanosensory behavior (GO:0007638) | 3.92709741 |
| 45 | innervation (GO:0060384) | 3.86148154 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 3.83281255 |
| 47 | dopamine biosynthetic process (GO:0042416) | 3.82955014 |
| 48 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.82146477 |
| 49 | neuron recognition (GO:0008038) | 3.82006558 |
| 50 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 3.81899294 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.79280508 |
| 52 | response to auditory stimulus (GO:0010996) | 3.74038314 |
| 53 | startle response (GO:0001964) | 3.73847152 |
| 54 | negative chemotaxis (GO:0050919) | 3.72227702 |
| 55 | establishment of nucleus localization (GO:0040023) | 3.71808440 |
| 56 | primary amino compound metabolic process (GO:1901160) | 3.70385400 |
| 57 | regulation of acrosome reaction (GO:0060046) | 3.67834107 |
| 58 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.66939262 |
| 59 | nerve growth factor signaling pathway (GO:0038180) | 3.66415271 |
| 60 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.66034375 |
| 61 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.65101276 |
| 62 | atrial cardiac muscle cell action potential (GO:0086014) | 3.64744533 |
| 63 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.60539367 |
| 64 | opioid receptor signaling pathway (GO:0038003) | 3.59866296 |
| 65 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.57480351 |
| 66 | regulation of synapse assembly (GO:0051963) | 3.54349302 |
| 67 | glutamate receptor signaling pathway (GO:0007215) | 3.54192381 |
| 68 | regulation of sarcomere organization (GO:0060297) | 3.53627268 |
| 69 | facial nerve structural organization (GO:0021612) | 3.51335842 |
| 70 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.50462126 |
| 71 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.50126569 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.46658731 |
| 73 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.44997040 |
| 74 | neuron-neuron synaptic transmission (GO:0007270) | 3.44916627 |
| 75 | positive regulation of microtubule polymerization (GO:0031116) | 3.43243273 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 3.42687820 |
| 77 | dermatan sulfate metabolic process (GO:0030205) | 3.42141706 |
| 78 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.41654181 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.41422034 |
| 80 | heart field specification (GO:0003128) | 3.39461324 |
| 81 | secondary heart field specification (GO:0003139) | 3.39461324 |
| 82 | axon extension (GO:0048675) | 3.37244957 |
| 83 | positive regulation of synapse assembly (GO:0051965) | 3.35247508 |
| 84 | nucleobase catabolic process (GO:0046113) | 3.34469493 |
| 85 | neurotransmitter biosynthetic process (GO:0042136) | 3.33668745 |
| 86 | midbrain development (GO:0030901) | 3.32703541 |
| 87 | astrocyte differentiation (GO:0048708) | 3.30820623 |
| 88 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.29468793 |
| 89 | mitochondrial genome maintenance (GO:0000002) | 3.29146794 |
| 90 | regulation of somitogenesis (GO:0014807) | 3.28559600 |
| 91 | glomerular filtration (GO:0003094) | 3.26755713 |
| 92 | behavioral defense response (GO:0002209) | 3.25197684 |
| 93 | behavioral fear response (GO:0001662) | 3.25197684 |
| 94 | regulation of neuron projection regeneration (GO:0070570) | 3.24455174 |
| 95 | regulation of axon regeneration (GO:0048679) | 3.24455174 |
| 96 | negative regulation of axon extension (GO:0030517) | 3.24153871 |
| 97 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.23351941 |
| 98 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.22760566 |
| 99 | multicellular organism reproduction (GO:0032504) | 3.22650891 |
| 100 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21866933 |
| 101 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.21116478 |
| 102 | cranial nerve structural organization (GO:0021604) | 3.20874523 |
| 103 | retina layer formation (GO:0010842) | 3.20591809 |
| 104 | positive regulation of vascular permeability (GO:0043117) | 3.20339505 |
| 105 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.15191259 |
| 106 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.13651158 |
| 107 | meiotic cell cycle (GO:0051321) | 3.13574939 |
| 108 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.11712788 |
| 109 | negative regulation of dendrite development (GO:2000171) | 3.09197263 |
| 110 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.08972237 |
| 111 | neuronal action potential (GO:0019228) | 3.08593383 |
| 112 | piRNA metabolic process (GO:0034587) | 3.08258634 |
| 113 | protein localization to synapse (GO:0035418) | 3.05672622 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 3.05273394 |
| 115 | neuron maturation (GO:0042551) | 3.05094809 |
| 116 | glycine transport (GO:0015816) | 3.04367014 |
| 117 | forebrain neuron differentiation (GO:0021879) | 3.03147269 |
| 118 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.02790167 |
| 119 | fear response (GO:0042596) | 3.01787226 |
| 120 | neuronal action potential propagation (GO:0019227) | 3.01114891 |
| 121 | regulation of postsynaptic membrane potential (GO:0060078) | 3.00695301 |
| 122 | membrane assembly (GO:0071709) | 3.00222684 |
| 123 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.00221924 |
| 124 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.99679628 |
| 125 | membrane depolarization during action potential (GO:0086010) | 2.99409385 |
| 126 | microtubule severing (GO:0051013) | 2.98548571 |
| 127 | dendritic spine morphogenesis (GO:0060997) | 2.97645071 |
| 128 | synaptic vesicle exocytosis (GO:0016079) | 2.95208285 |
| 129 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.93656357 |
| 130 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.92349338 |
| 131 | positive regulation of action potential (GO:0045760) | 2.91684098 |
| 132 | regulation of synapse organization (GO:0050807) | 2.91314283 |
| 133 | establishment of tissue polarity (GO:0007164) | 2.91211807 |
| 134 | establishment of planar polarity (GO:0001736) | 2.91211807 |
| 135 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.91089860 |
| 136 | negative regulation of neurotransmitter transport (GO:0051589) | 2.90658051 |
| 137 | response to histamine (GO:0034776) | 2.88954175 |
| 138 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88562546 |
| 139 | drinking behavior (GO:0042756) | 2.87010512 |
| 140 | paraxial mesoderm development (GO:0048339) | 2.86517396 |
| 141 | regulation of dopamine metabolic process (GO:0042053) | 2.85190942 |
| 142 | regulation of catecholamine metabolic process (GO:0042069) | 2.85190942 |
| 143 | monoamine transport (GO:0015844) | 2.84541437 |
| 144 | membrane depolarization (GO:0051899) | 2.83942848 |
| 145 | protein localization to kinetochore (GO:0034501) | 2.83389822 |
| 146 | synapse assembly (GO:0007416) | 2.83282322 |
| 147 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.81064038 |
| 148 | negative regulation of reproductive process (GO:2000242) | 2.79830273 |
| 149 | central nervous system neuron axonogenesis (GO:0021955) | 2.79237549 |
| 150 | cardiac ventricle formation (GO:0003211) | 2.78985582 |
| 151 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77375878 |
| 152 | neuron fate determination (GO:0048664) | 2.77123250 |
| 153 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.76006837 |
| 154 | glomerular basement membrane development (GO:0032836) | 2.75206700 |
| 155 | prostate gland growth (GO:0060736) | 2.74567196 |
| 156 | central nervous system neuron development (GO:0021954) | 2.73877690 |
| 157 | prepulse inhibition (GO:0060134) | 2.72293039 |
| 158 | regulation of synapse maturation (GO:0090128) | 2.71773422 |
| 159 | cartilage morphogenesis (GO:0060536) | 2.71733456 |
| 160 | hindbrain development (GO:0030902) | 2.71209119 |
| 161 | positive regulation of membrane potential (GO:0045838) | 2.70843503 |
| 162 | regulation of action potential (GO:0098900) | 2.70104675 |
| 163 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.69147058 |
| 164 | behavioral response to cocaine (GO:0048148) | 2.68221194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.35005007 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.56006334 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98138800 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95139574 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94998055 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.77613443 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.75329157 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67199222 |
| 9 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.65947353 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65455924 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.60155356 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.55893241 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52132635 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52132635 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47000966 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45115067 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42227740 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38264550 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.31696575 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24849416 |
| 21 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.23765173 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22006399 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.21864952 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20479232 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17617551 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15557411 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14614958 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03840457 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02939476 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98353400 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96424316 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.96314346 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93542804 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88204955 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87695391 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.87519968 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.85971264 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85586874 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84881305 |
| 40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.82663693 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80315330 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67622460 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63735551 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.62914627 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62469297 |
| 46 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59981479 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56734240 |
| 48 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54213608 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51038420 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.50441095 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49639270 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48021732 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47369357 |
| 54 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.44369933 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42092072 |
| 56 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41760638 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38499677 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34667579 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32939030 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28472691 |
| 61 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26435393 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25982134 |
| 63 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25406460 |
| 64 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24921430 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24558009 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24521843 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24137856 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23842510 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23842510 |
| 70 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23348584 |
| 71 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22635462 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21911795 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20241346 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19737663 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19576857 |
| 76 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19192227 |
| 77 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.18647409 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18309529 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17712246 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17589686 |
| 81 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16082086 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15384329 |
| 83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14315129 |
| 84 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12132085 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11702712 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.11552271 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11127956 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10213685 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10057047 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09609199 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09268962 |
| 92 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08864519 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07791007 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07646635 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07646635 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07102749 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06864685 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06750961 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05454476 |
| 100 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05032527 |
| 101 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04122249 |
| 102 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03072046 |
| 103 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02154150 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.02091563 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02018258 |
| 106 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02009352 |
| 107 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01936116 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 1.01184368 |
| 109 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00012515 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99483769 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99427006 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99233160 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99128169 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97633482 |
| 115 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97049861 |
| 116 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96791333 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96537554 |
| 118 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.96176793 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95802514 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95407927 |
| 121 | AR_19668381_ChIP-Seq_PC3_Human | 0.94868485 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94177758 |
| 123 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93752667 |
| 124 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92156642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 5.46263049 |
| 2 | MP0003880_abnormal_central_pattern | 5.11644715 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.26567928 |
| 4 | MP0005423_abnormal_somatic_nervous | 4.14639163 |
| 5 | MP0001529_abnormal_vocalization | 3.67675200 |
| 6 | MP0006276_abnormal_autonomic_nervous | 3.23507011 |
| 7 | MP0000566_synostosis | 3.14663389 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.95560776 |
| 9 | MP0003718_maternal_effect | 2.84424488 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.73642055 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.66330750 |
| 12 | MP0002736_abnormal_nociception_after | 2.62400562 |
| 13 | MP0000778_abnormal_nervous_system | 2.54487731 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.41852246 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.38792791 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.38229559 |
| 17 | MP0009745_abnormal_behavioral_response | 2.25255076 |
| 18 | MP0002064_seizures | 2.18670278 |
| 19 | MP0009046_muscle_twitch | 2.11851202 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.05147188 |
| 21 | MP0001486_abnormal_startle_reflex | 1.97127949 |
| 22 | MP0008789_abnormal_olfactory_epithelium | 1.90411279 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.88204435 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.84921386 |
| 25 | MP0002184_abnormal_innervation | 1.83922107 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.82167779 |
| 27 | MP0001905_abnormal_dopamine_level | 1.79756957 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.78814150 |
| 29 | MP0005171_absent_coat_pigmentation | 1.77934273 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.75173527 |
| 31 | MP0003122_maternal_imprinting | 1.73209563 |
| 32 | MP0004924_abnormal_behavior | 1.71583166 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.71583166 |
| 34 | MP0002751_abnormal_autonomic_nervous | 1.68908504 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.68765978 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.67354908 |
| 37 | MP0005377_hearing/vestibular/ear_phenot | 1.65636138 |
| 38 | MP0003878_abnormal_ear_physiology | 1.65636138 |
| 39 | MP0002272_abnormal_nervous_system | 1.63485530 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.59596552 |
| 41 | MP0003119_abnormal_digestive_system | 1.58961985 |
| 42 | MP0002938_white_spotting | 1.55744178 |
| 43 | MP0002102_abnormal_ear_morphology | 1.53191481 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.51284863 |
| 45 | MP0001188_hyperpigmentation | 1.47786198 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.47769252 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.46315343 |
| 48 | MP0003938_abnormal_ear_development | 1.46253346 |
| 49 | MP0005187_abnormal_penis_morphology | 1.44511507 |
| 50 | MP0000955_abnormal_spinal_cord | 1.43967571 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.43809325 |
| 52 | MP0002734_abnormal_mechanical_nocicepti | 1.40205372 |
| 53 | MP0008057_abnormal_DNA_replication | 1.37843009 |
| 54 | MP0004742_abnormal_vestibular_system | 1.36099280 |
| 55 | MP0003283_abnormal_digestive_organ | 1.34240906 |
| 56 | MP0000026_abnormal_inner_ear | 1.31986533 |
| 57 | MP0008569_lethality_at_weaning | 1.27364149 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.25121295 |
| 59 | MP0004133_heterotaxia | 1.22434413 |
| 60 | MP0003787_abnormal_imprinting | 1.20866657 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.18975229 |
| 62 | MP0004142_abnormal_muscle_tone | 1.18866782 |
| 63 | MP0005395_other_phenotype | 1.17548514 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.17141925 |
| 65 | MP0009697_abnormal_copulation | 1.15698143 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.15198530 |
| 67 | MP0004858_abnormal_nervous_system | 1.13914716 |
| 68 | MP0002066_abnormal_motor_capabilities/c | 1.13348483 |
| 69 | MP0008872_abnormal_physiological_respon | 1.13010167 |
| 70 | MP0001970_abnormal_pain_threshold | 1.12645029 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 1.10983148 |
| 72 | MP0004270_analgesia | 1.10376382 |
| 73 | MP0001984_abnormal_olfaction | 1.08534095 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.06787765 |
| 75 | MP0009379_abnormal_foot_pigmentation | 1.06771361 |
| 76 | MP0002152_abnormal_brain_morphology | 1.05636175 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.99443156 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 0.97437403 |
| 79 | MP0000516_abnormal_urinary_system | 0.97437403 |
| 80 | MP0001502_abnormal_circadian_rhythm | 0.97081729 |
| 81 | MP0001664_abnormal_digestion | 0.91068595 |
| 82 | MP0003861_abnormal_nervous_system | 0.90792221 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.89954026 |
| 84 | MP0003942_abnormal_urinary_system | 0.89355280 |
| 85 | MP0002095_abnormal_skin_pigmentation | 0.88743893 |
| 86 | MP0003121_genomic_imprinting | 0.88364101 |
| 87 | MP0003699_abnormal_female_reproductive | 0.88079180 |
| 88 | MP0003879_abnormal_hair_cell | 0.87518189 |
| 89 | MP0003959_abnormal_lean_body | 0.87307235 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.87114758 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.84545103 |
| 92 | MP0002210_abnormal_sex_determination | 0.83585929 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.82008582 |
| 94 | MP0008004_abnormal_stomach_pH | 0.81133466 |
| 95 | MP0000427_abnormal_hair_cycle | 0.80423923 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.79855423 |
| 97 | MP0004043_abnormal_pH_regulation | 0.79808356 |
| 98 | MP0001929_abnormal_gametogenesis | 0.79149892 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.79016666 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.78980583 |
| 101 | MP0000647_abnormal_sebaceous_gland | 0.77336716 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.76593561 |
| 103 | MP0002932_abnormal_joint_morphology | 0.75772405 |
| 104 | MP0005670_abnormal_white_adipose | 0.75691358 |
| 105 | MP0005535_abnormal_body_temperature | 0.74419723 |
| 106 | MP0002161_abnormal_fertility/fecundity | 0.73469484 |
| 107 | MP0003698_abnormal_male_reproductive | 0.73261929 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.73111390 |
| 109 | MP0003633_abnormal_nervous_system | 0.72471884 |
| 110 | MP0005410_abnormal_fertilization | 0.70484770 |
| 111 | MP0002177_abnormal_outer_ear | 0.70308222 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.69004632 |
| 113 | MP0003693_abnormal_embryo_hatching | 0.68437439 |
| 114 | MP0005499_abnormal_olfactory_system | 0.68086786 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.68086786 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.68023643 |
| 117 | MP0000653_abnormal_sex_gland | 0.68008998 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.67758547 |
| 119 | MP0003631_nervous_system_phenotype | 0.67403637 |
| 120 | MP0002163_abnormal_gland_morphology | 0.65162091 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.64675442 |
| 122 | MP0002233_abnormal_nose_morphology | 0.64516543 |
| 123 | MP0000383_abnormal_hair_follicle | 0.62986543 |
| 124 | MP0003385_abnormal_body_wall | 0.62662686 |
| 125 | MP0000049_abnormal_middle_ear | 0.62130991 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.62111550 |
| 127 | MP0005174_abnormal_tail_pigmentation | 0.62022423 |
| 128 | MP0003937_abnormal_limbs/digits/tail_de | 0.61662658 |
| 129 | MP0002229_neurodegeneration | 0.60778187 |
| 130 | MP0001943_abnormal_respiration | 0.60775033 |
| 131 | MP0003868_abnormal_feces_composition | 0.60322862 |
| 132 | MP0002127_abnormal_cardiovascular_syste | 0.59170895 |
| 133 | MP0004085_abnormal_heartbeat | 0.58802567 |
| 134 | MP0000534_abnormal_ureter_morphology | 0.58437824 |
| 135 | MP0004885_abnormal_endolymph | 0.57863783 |
| 136 | MP0003890_abnormal_embryonic-extraembry | 0.56920858 |
| 137 | MP0005448_abnormal_energy_balance | 0.55574216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.50806851 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.40351713 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 4.40351713 |
| 4 | Limb dystonia (HP:0002451) | 4.37964722 |
| 5 | Focal motor seizures (HP:0011153) | 4.22447833 |
| 6 | Hyperventilation (HP:0002883) | 4.07528403 |
| 7 | Hypothermia (HP:0002045) | 4.02091287 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.92393058 |
| 9 | Febrile seizures (HP:0002373) | 3.82737845 |
| 10 | Exotropia (HP:0000577) | 3.50720618 |
| 11 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.47546799 |
| 12 | Protruding tongue (HP:0010808) | 3.44924277 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 3.43078120 |
| 14 | Short tibia (HP:0005736) | 3.37570469 |
| 15 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.37328305 |
| 16 | Abnormal ciliary motility (HP:0012262) | 3.30876669 |
| 17 | Inability to walk (HP:0002540) | 3.30703286 |
| 18 | Parakeratosis (HP:0001036) | 3.25386363 |
| 19 | Fair hair (HP:0002286) | 3.18790332 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.01386700 |
| 21 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.91515878 |
| 22 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.91515878 |
| 23 | Septo-optic dysplasia (HP:0100842) | 2.90833349 |
| 24 | Anomalous pulmonary venous return (HP:0010772) | 2.88097038 |
| 25 | Focal seizures (HP:0007359) | 2.78062488 |
| 26 | Medulloblastoma (HP:0002885) | 2.75611445 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 2.72662963 |
| 28 | Abnormality of the right ventricle (HP:0001707) | 2.69423614 |
| 29 | Impaired social interactions (HP:0000735) | 2.68301292 |
| 30 | Abnormal social behavior (HP:0012433) | 2.68301292 |
| 31 | Atonic seizures (HP:0010819) | 2.67630420 |
| 32 | Broad-based gait (HP:0002136) | 2.67274020 |
| 33 | Midline defect of the nose (HP:0004122) | 2.66337749 |
| 34 | Impulsivity (HP:0100710) | 2.64780468 |
| 35 | Supernumerary spleens (HP:0009799) | 2.64074211 |
| 36 | Amblyopia (HP:0000646) | 2.60940156 |
| 37 | Hepatoblastoma (HP:0002884) | 2.58141427 |
| 38 | Agitation (HP:0000713) | 2.57864482 |
| 39 | Aplasia of the musculature (HP:0100854) | 2.56957019 |
| 40 | Mutism (HP:0002300) | 2.55210728 |
| 41 | Facial hemangioma (HP:0000329) | 2.54650753 |
| 42 | Colon cancer (HP:0003003) | 2.51121515 |
| 43 | Myokymia (HP:0002411) | 2.50612488 |
| 44 | Concave nail (HP:0001598) | 2.48794955 |
| 45 | Thyroid-stimulating hormone excess (HP:0002925) | 2.46844655 |
| 46 | Chorioretinal atrophy (HP:0000533) | 2.45148315 |
| 47 | Gait imbalance (HP:0002141) | 2.43629771 |
| 48 | Dialeptic seizures (HP:0011146) | 2.43552793 |
| 49 | Action tremor (HP:0002345) | 2.43431215 |
| 50 | Anosmia (HP:0000458) | 2.42923990 |
| 51 | Hyperactive renin-angiotensin system (HP:0000841) | 2.40719128 |
| 52 | Generalized hypopigmentation of hair (HP:0011358) | 2.38560973 |
| 53 | Unilateral renal agenesis (HP:0000122) | 2.37137936 |
| 54 | Absence seizures (HP:0002121) | 2.36219594 |
| 55 | Hypoventilation (HP:0002791) | 2.34554614 |
| 56 | Atrioventricular canal defect (HP:0006695) | 2.34414894 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.34231369 |
| 58 | Thyroid carcinoma (HP:0002890) | 2.33701256 |
| 59 | Abnormality of the pulmonary veins (HP:0011718) | 2.32048902 |
| 60 | Neoplasm of the oral cavity (HP:0100649) | 2.31033825 |
| 61 | Acute lymphatic leukemia (HP:0006721) | 2.30663767 |
| 62 | Absent speech (HP:0001344) | 2.29995211 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.29577407 |
| 64 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.27067590 |
| 65 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25396778 |
| 66 | Narrow nasal bridge (HP:0000446) | 2.22620479 |
| 67 | Type II lissencephaly (HP:0007260) | 2.22485204 |
| 68 | Complete atrioventricular canal defect (HP:0001674) | 2.22140714 |
| 69 | Decreased circulating renin level (HP:0003351) | 2.21790715 |
| 70 | Absent septum pellucidum (HP:0001331) | 2.21053396 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.19294889 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18866511 |
| 73 | Microglossia (HP:0000171) | 2.17555022 |
| 74 | Anophthalmia (HP:0000528) | 2.17549708 |
| 75 | Progressive inability to walk (HP:0002505) | 2.17457712 |
| 76 | Fibular aplasia (HP:0002990) | 2.17067355 |
| 77 | Increased number of teeth (HP:0011069) | 2.15938213 |
| 78 | Optic nerve hypoplasia (HP:0000609) | 2.14892378 |
| 79 | Tented upper lip vermilion (HP:0010804) | 2.14089214 |
| 80 | Abnormality of the septum pellucidum (HP:0007375) | 2.13837571 |
| 81 | Hypsarrhythmia (HP:0002521) | 2.13307346 |
| 82 | Esotropia (HP:0000565) | 2.13226843 |
| 83 | Abnormality of macular pigmentation (HP:0008002) | 2.13033845 |
| 84 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.12725567 |
| 85 | Short chin (HP:0000331) | 2.11660966 |
| 86 | Truncal ataxia (HP:0002078) | 2.11616496 |
| 87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.11069313 |
| 88 | Short 4th metacarpal (HP:0010044) | 2.11069313 |
| 89 | Vitreoretinal degeneration (HP:0000655) | 2.10254672 |
| 90 | Shoulder girdle muscle weakness (HP:0003547) | 2.08124158 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08015501 |
| 92 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07196729 |
| 93 | Diplopia (HP:0000651) | 2.06746026 |
| 94 | Abnormality of binocular vision (HP:0011514) | 2.06746026 |
| 95 | Stomach cancer (HP:0012126) | 2.06691925 |
| 96 | Apathy (HP:0000741) | 2.06271013 |
| 97 | Diminished motivation (HP:0000745) | 2.04866848 |
| 98 | Severe Myopia (HP:0011003) | 2.04309278 |
| 99 | Anterior segment dysgenesis (HP:0007700) | 2.02670752 |
| 100 | Abnormality of the fovea (HP:0000493) | 2.01146056 |
| 101 | Morphological abnormality of the middle ear (HP:0008609) | 2.00670233 |
| 102 | True hermaphroditism (HP:0010459) | 2.00017589 |
| 103 | Abnormality of salivation (HP:0100755) | 1.99210110 |
| 104 | Prolonged QT interval (HP:0001657) | 1.98414370 |
| 105 | Renal Fanconi syndrome (HP:0001994) | 1.98141196 |
| 106 | Lissencephaly (HP:0001339) | 1.97166015 |
| 107 | Poor head control (HP:0002421) | 1.97103820 |
| 108 | Cutaneous finger syndactyly (HP:0010554) | 1.96613273 |
| 109 | Open mouth (HP:0000194) | 1.95723092 |
| 110 | Maternal diabetes (HP:0009800) | 1.94932277 |
| 111 | Absent eyebrow (HP:0002223) | 1.93265782 |
| 112 | Abnormality of the labia minora (HP:0012880) | 1.91816559 |
| 113 | Gastroesophageal reflux (HP:0002020) | 1.91770152 |
| 114 | Volvulus (HP:0002580) | 1.91742392 |
| 115 | Failure to thrive in infancy (HP:0001531) | 1.91153268 |
| 116 | Abnormal eating behavior (HP:0100738) | 1.89966871 |
| 117 | Intellectual disability, severe (HP:0010864) | 1.88674488 |
| 118 | Pachygyria (HP:0001302) | 1.87286777 |
| 119 | Medial flaring of the eyebrow (HP:0010747) | 1.86382244 |
| 120 | Astrocytoma (HP:0009592) | 1.85831863 |
| 121 | Abnormality of the astrocytes (HP:0100707) | 1.85831863 |
| 122 | Fetal akinesia sequence (HP:0001989) | 1.85765460 |
| 123 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.85676571 |
| 124 | Abnormal sex determination (HP:0012244) | 1.84638042 |
| 125 | Sex reversal (HP:0012245) | 1.84638042 |
| 126 | Central scotoma (HP:0000603) | 1.83601957 |
| 127 | Generalized tonic-clonic seizures (HP:0002069) | 1.82887189 |
| 128 | Omphalocele (HP:0001539) | 1.82833695 |
| 129 | Macroglossia (HP:0000158) | 1.82693034 |
| 130 | Genetic anticipation (HP:0003743) | 1.82415920 |
| 131 | Exertional dyspnea (HP:0002875) | 1.81518234 |
| 132 | Large earlobe (HP:0009748) | 1.81152276 |
| 133 | Drooling (HP:0002307) | 1.80378467 |
| 134 | Excessive salivation (HP:0003781) | 1.80378467 |
| 135 | Hypoplasia of the pons (HP:0012110) | 1.79944242 |
| 136 | Shawl scrotum (HP:0000049) | 1.79694860 |
| 137 | Growth hormone deficiency (HP:0000824) | 1.79600286 |
| 138 | Absent eyelashes (HP:0000561) | 1.79495037 |
| 139 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.78707945 |
| 140 | Nephronophthisis (HP:0000090) | 1.78133212 |
| 141 | Epidermoid cyst (HP:0200040) | 1.77160539 |
| 142 | Genital tract atresia (HP:0001827) | 1.76993798 |
| 143 | Blue irides (HP:0000635) | 1.76853935 |
| 144 | Poor eye contact (HP:0000817) | 1.76620112 |
| 145 | Bifid tongue (HP:0010297) | 1.76594768 |
| 146 | Widely spaced teeth (HP:0000687) | 1.76034738 |
| 147 | Abnormality of the corticospinal tract (HP:0002492) | 1.75830171 |
| 148 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.75051230 |
| 149 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.75051230 |
| 150 | Oligodactyly (hands) (HP:0001180) | 1.74896000 |
| 151 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73850602 |
| 152 | Bilateral microphthalmos (HP:0007633) | 1.73676341 |
| 153 | Cerebral inclusion bodies (HP:0100314) | 1.73440715 |
| 154 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.73308114 |
| 155 | Hypoplasia of the brainstem (HP:0002365) | 1.73308114 |
| 156 | Syncope (HP:0001279) | 1.73197307 |
| 157 | Spinal cord compression (HP:0002176) | 1.73144049 |
| 158 | Specific learning disability (HP:0001328) | 1.72068882 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.70896319 |
| 160 | Polyphagia (HP:0002591) | 1.70688824 |
| 161 | Arterial tortuosity (HP:0005116) | 1.70519748 |
| 162 | Aplasia involving bones of the extremities (HP:0009825) | 1.70220672 |
| 163 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.70220672 |
| 164 | Aplasia of the phalanges of the hand (HP:0009802) | 1.70220672 |
| 165 | Renal dysplasia (HP:0000110) | 1.70099815 |
| 166 | Recurrent corneal erosions (HP:0000495) | 1.69123624 |
| 167 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.68896131 |
| 168 | Clumsiness (HP:0002312) | 1.67522317 |
| 169 | Absent epiphyses (HP:0010577) | 1.67478829 |
| 170 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.67478829 |
| 171 | Decreased central vision (HP:0007663) | 1.67277318 |
| 172 | Lipid accumulation in hepatocytes (HP:0006561) | 1.66060647 |
| 173 | Meningocele (HP:0002435) | 1.65928527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 5.89388383 |
| 2 | NTRK3 | 4.05393071 |
| 3 | TNIK | 3.59974204 |
| 4 | NTRK2 | 3.29495888 |
| 5 | CASK | 3.18460141 |
| 6 | STK16 | 3.14793417 |
| 7 | FGFR2 | 3.12885980 |
| 8 | EPHA4 | 3.03206571 |
| 9 | WNK3 | 2.68068806 |
| 10 | KSR1 | 2.52170407 |
| 11 | PDK2 | 2.38320152 |
| 12 | TYRO3 | 2.37265924 |
| 13 | MAP3K9 | 2.11716827 |
| 14 | MAP3K12 | 1.92040477 |
| 15 | MINK1 | 1.75998566 |
| 16 | MARK1 | 1.70330471 |
| 17 | BCR | 1.69325182 |
| 18 | PLK2 | 1.54468669 |
| 19 | TAOK2 | 1.52555839 |
| 20 | CSNK1G2 | 1.52256205 |
| 21 | CDK19 | 1.51530586 |
| 22 | SIK1 | 1.47023425 |
| 23 | IRAK2 | 1.44650248 |
| 24 | SIK2 | 1.42325289 |
| 25 | FGFR4 | 1.42321332 |
| 26 | TAOK3 | 1.41130382 |
| 27 | MAPK13 | 1.34119309 |
| 28 | MAPK12 | 1.28195095 |
| 29 | MAP2K7 | 1.25736158 |
| 30 | PDGFRA | 1.25062151 |
| 31 | ERBB3 | 1.19119348 |
| 32 | MAP2K4 | 1.17674781 |
| 33 | PHKG2 | 1.15146231 |
| 34 | PHKG1 | 1.15146231 |
| 35 | FRK | 1.14613435 |
| 36 | BRD4 | 1.14580821 |
| 37 | MELK | 1.13760277 |
| 38 | GRK7 | 1.13602010 |
| 39 | BRAF | 1.13526306 |
| 40 | CCNB1 | 1.07638819 |
| 41 | MARK2 | 1.04801267 |
| 42 | FGR | 1.03999189 |
| 43 | TRIM28 | 1.03424513 |
| 44 | CSNK1G3 | 1.02790036 |
| 45 | YES1 | 1.00779345 |
| 46 | CDC42BPA | 0.98831592 |
| 47 | PRPF4B | 0.97702797 |
| 48 | EPHB2 | 0.93839429 |
| 49 | MAP3K6 | 0.93001933 |
| 50 | UHMK1 | 0.92353845 |
| 51 | PRKCG | 0.91037775 |
| 52 | FGFR1 | 0.90919811 |
| 53 | CAMK2A | 0.87958326 |
| 54 | DYRK1A | 0.85055352 |
| 55 | CDK5 | 0.79669482 |
| 56 | CSNK1A1L | 0.76961172 |
| 57 | ADRBK1 | 0.76315418 |
| 58 | DAPK2 | 0.75966579 |
| 59 | PRKCE | 0.74748165 |
| 60 | TSSK6 | 0.71474587 |
| 61 | DAPK1 | 0.70880485 |
| 62 | STK38 | 0.70497549 |
| 63 | PRKD2 | 0.69609180 |
| 64 | BMPR1B | 0.69602437 |
| 65 | VRK1 | 0.69361476 |
| 66 | CAMK2B | 0.67957347 |
| 67 | CDK18 | 0.67622458 |
| 68 | ADRBK2 | 0.66535681 |
| 69 | OXSR1 | 0.66407623 |
| 70 | ARAF | 0.66088704 |
| 71 | BRSK1 | 0.65876733 |
| 72 | PAK6 | 0.64674296 |
| 73 | MAPK7 | 0.64486998 |
| 74 | PRKCQ | 0.64372958 |
| 75 | EPHA3 | 0.63840978 |
| 76 | PAK3 | 0.63302064 |
| 77 | CDK9 | 0.62226823 |
| 78 | RAF1 | 0.61312291 |
| 79 | PINK1 | 0.60426727 |
| 80 | CSNK1G1 | 0.58911020 |
| 81 | MAP2K6 | 0.57165858 |
| 82 | AKT3 | 0.56828671 |
| 83 | TLK1 | 0.54719170 |
| 84 | DDR2 | 0.54632691 |
| 85 | TNK2 | 0.53941950 |
| 86 | DYRK2 | 0.53786394 |
| 87 | GRK5 | 0.53363941 |
| 88 | RIPK4 | 0.53304803 |
| 89 | DYRK1B | 0.52537226 |
| 90 | NEK6 | 0.52261009 |
| 91 | MAPK4 | 0.51112516 |
| 92 | GRK6 | 0.51090585 |
| 93 | CSNK1D | 0.50658232 |
| 94 | SGK1 | 0.50445370 |
| 95 | ABL2 | 0.49415159 |
| 96 | CDK15 | 0.48674517 |
| 97 | NUAK1 | 0.48617293 |
| 98 | CAMK1 | 0.48022351 |
| 99 | ACVR1B | 0.46912901 |
| 100 | ERBB2 | 0.46265747 |
| 101 | RET | 0.45034615 |
| 102 | SGK494 | 0.44584372 |
| 103 | SGK223 | 0.44584372 |
| 104 | MARK3 | 0.43988434 |
| 105 | PRKCI | 0.43296397 |
| 106 | PKN1 | 0.42000965 |
| 107 | INSRR | 0.41954550 |
| 108 | CDK11A | 0.41514051 |
| 109 | CDK8 | 0.41161882 |
| 110 | LATS2 | 0.40400970 |
| 111 | STK39 | 0.40220693 |
| 112 | MKNK2 | 0.40164492 |
| 113 | PNCK | 0.39388393 |
| 114 | FGFR3 | 0.38539337 |
| 115 | ROCK2 | 0.37874977 |
| 116 | PRKG1 | 0.37325398 |
| 117 | PRKACB | 0.37322154 |
| 118 | PRKACA | 0.36704573 |
| 119 | EIF2AK2 | 0.36006768 |
| 120 | MET | 0.35606489 |
| 121 | CAMKK2 | 0.35319080 |
| 122 | IRAK1 | 0.35042072 |
| 123 | TESK2 | 0.34929380 |
| 124 | TGFBR1 | 0.33869577 |
| 125 | SGK2 | 0.33814757 |
| 126 | AKT2 | 0.33540440 |
| 127 | FYN | 0.32132902 |
| 128 | PRKCZ | 0.31821163 |
| 129 | MAPK15 | 0.31741210 |
| 130 | AURKA | 0.31351503 |
| 131 | CSNK1E | 0.31129468 |
| 132 | MAP3K5 | 0.31025191 |
| 133 | CDK14 | 0.30457671 |
| 134 | CSNK1A1 | 0.29242076 |
| 135 | MAP3K4 | 0.29109954 |
| 136 | STK11 | 0.28511794 |
| 137 | GSK3B | 0.25068786 |
| 138 | RPS6KA3 | 0.19228399 |
| 139 | CDC7 | 0.19193401 |
| 140 | CHEK2 | 0.18878183 |
| 141 | CSF1R | 0.17213179 |
| 142 | PRKCB | 0.15888968 |
| 143 | FLT3 | 0.15027244 |
| 144 | EIF2AK3 | 0.14854624 |
| 145 | GSK3A | 0.14693040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 5.23250880 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.25041094 |
| 3 | Cocaine addiction_Homo sapiens_hsa05030 | 3.14594758 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 3.03375938 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.86452240 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83580726 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72793999 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.69329459 |
| 9 | Taste transduction_Homo sapiens_hsa04742 | 2.63476948 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.60991724 |
| 11 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.46634290 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 2.44578111 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.30849748 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 2.23716189 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09580631 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.74558347 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.73306895 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.71145848 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70621878 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.65531460 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.65403613 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.62041159 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53805286 |
| 24 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.52460647 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.51221271 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.48709653 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.37617296 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.34537779 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.32879426 |
| 30 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.23233155 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20898902 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.14617270 |
| 33 | Melanogenesis_Homo sapiens_hsa04916 | 1.13718082 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11471066 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11379919 |
| 36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10338714 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09020882 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.07582654 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02266991 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01675812 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01480328 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99635582 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99540043 |
| 44 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.99016729 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95499238 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90131309 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87611010 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87306610 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85776394 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84325863 |
| 51 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.83625191 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83128568 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81918788 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81583676 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80590703 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79064084 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78117048 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77693232 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76166950 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75895035 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74781902 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74529095 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.72494514 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 0.71385575 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71097841 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70872920 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.69860510 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.68786697 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68466800 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67527475 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.65696503 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64263719 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.63198932 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60952138 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.60761426 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57899424 |
| 77 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57223088 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56259665 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56053112 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55307442 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54270809 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54155665 |
| 83 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54023214 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52690385 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52493792 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52023139 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51560477 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49521018 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43869177 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42597238 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42485186 |
| 92 | RNA polymerase_Homo sapiens_hsa03020 | 0.42113192 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41195229 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | 0.40503682 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39813474 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39615507 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.39311799 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.38665172 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38587283 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37593244 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36953338 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36781663 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36695676 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36114068 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35631783 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.34723892 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32855906 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32201982 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31855888 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31743588 |
| 111 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31429427 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29924504 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29372474 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28985849 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28659334 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.28115557 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27587227 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26868137 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.26502000 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26049943 |
| 121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25642156 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25631882 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25620560 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24954150 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23390040 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22406104 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19044684 |

